LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Disorders of renal magnesium handling explain renal magnesium transport.

Wagner, Carsten A

Journal of nephrology

2007  Volume 20, Issue 5, Page(s) 507–510

Abstract: ... magnesium balance as evident from several rare inherited disorders of renal magnesium transport. Recent ... studies shed new light on molecular mechanisms of renal magnesium handling and its control. Mutations ... in distal tubules found in patients with renal magnesium wasting and hypomagnesemia underscore ...

Abstract Magnesium is essential for bone stability, neuronal excitability, muscular relaxation and many other metabolic functions. Despite its fundamental biological importance, mechanisms controlling systemic magnesium homeostasis are only partially understood. The kidney plays a central role in maintaining magnesium balance as evident from several rare inherited disorders of renal magnesium transport. Recent studies shed new light on molecular mechanisms of renal magnesium handling and its control. Mutations in the claudin 16 (paracellin) paracellular protein in the thick ascending limb (TAL) of Henle's loop and in the transient receptor potential cation channel, subfamily 6, member 6 (TRPM6) magnesium channel expressed in distal tubules found in patients with renal magnesium wasting and hypomagnesemia underscore the importance of these transport proteins. A study by Hou et al (J Biol Chem 2007; 282: 17114-22) demonstrates a pathomechanism for claudin 16 mutations that gives interesting insights into the function of the TAL. Moreover, Groenestege and colleagues report (J Clin Invest 2007; 117: 2260-7) the identification of the epidermal growth factor (EGF) as a hormonal regulator of TRPM6 activity, and thereby explain how mutations in EGF can cause familial hypomagnesemia. Interestingly, cetuximab, a drug used in treatment of certain cancers, acts an inhibitor of the EGF receptor and causes hypomagnesemia which may be due to the inhibition of EGF signaling.
MeSH term(s) Animals ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal, Humanized ; Cetuximab ; Claudins ; Epidermal Growth Factor/genetics ; Epidermal Growth Factor/metabolism ; Genetic Predisposition to Disease ; Gitelman Syndrome/genetics ; Gitelman Syndrome/metabolism ; Homeostasis ; Humans ; Kidney/drug effects ; Kidney/metabolism ; Loop of Henle/metabolism ; Magnesium/metabolism ; Membrane Proteins/genetics ; Membrane Proteins/metabolism ; Metabolic Diseases/genetics ; Metabolic Diseases/metabolism ; Mutation ; Protein Kinase Inhibitors/pharmacology ; Receptor, Epidermal Growth Factor/antagonists & inhibitors ; Receptor, Epidermal Growth Factor/metabolism ; Signal Transduction/drug effects ; TRPM Cation Channels/genetics ; TRPM Cation Channels/metabolism
Chemical Substances Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized ; Claudins ; Membrane Proteins ; Protein Kinase Inhibitors ; TRPM Cation Channels ; TRPM6 protein, human ; claudin 16 ; Epidermal Growth Factor (62229-50-9) ; Receptor, Epidermal Growth Factor (EC 2.7.10.1) ; Magnesium (I38ZP9992A) ; Cetuximab (PQX0D8J21J)
Language English
Publishing date 2007-09
Publishing country Italy
Document type Journal Article ; Review
ZDB-ID 1093991-x
ISSN 1724-6059 ; 1121-8428 ; 1120-3625
ISSN (online) 1724-6059
ISSN 1121-8428 ; 1120-3625
Shelf mark
Zs.A 3369: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top